Market research
688098.SHG Shanghai Shen Lian Biomedical Corporation
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3B
- P/E ratio
- Not available
- Analyst target
- 9.3
- Dividend yield
- Not available
- Beta
- 0.55
Community
Investor discussion
1 comment
Sign in to join the 688098.SHG discussion.
5 years, 5 months ago
Shanghai Shen Lian Biomedical Corporation is currently in a long term downtrend where the price is trading 10.2% below its 200 day moving average.
From a valuation standpoint, the stock is 67.2% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 16.1.
Shanghai Shen Lian Biomedical Corporation's total revenue rose by 425.7% to $148M since the same quarter in the previous year.
Its net income has increased by 9191.0% to $77M since the same quarter in the previous year.
Finally, its free cash flow fell by 125.3% to $-3M since the same quarter in the previous year.
Based on the above factors, Shanghai Shen Lian Biomedical Corporation gets an overall score of 2/5.